KR890004558B1 - Process for preparing 4-amino-6,7-dimethoxy quinazoline derivatives - Google Patents

Process for preparing 4-amino-6,7-dimethoxy quinazoline derivatives Download PDF

Info

Publication number
KR890004558B1
KR890004558B1 KR1019870007670A KR870007670A KR890004558B1 KR 890004558 B1 KR890004558 B1 KR 890004558B1 KR 1019870007670 A KR1019870007670 A KR 1019870007670A KR 870007670 A KR870007670 A KR 870007670A KR 890004558 B1 KR890004558 B1 KR 890004558B1
Authority
KR
South Korea
Prior art keywords
formula
compound
reaction
amino
solvent
Prior art date
Application number
KR1019870007670A
Other languages
Korean (ko)
Other versions
KR890002125A (en
Inventor
이윤우
김동신
조양래
장대식
Original Assignee
대한약품공업 주식회사
문광석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대한약품공업 주식회사, 문광석 filed Critical 대한약품공업 주식회사
Priority to KR1019870007670A priority Critical patent/KR890004558B1/en
Priority to ES8802218A priority patent/ES2007263A6/en
Publication of KR890002125A publication Critical patent/KR890002125A/en
Application granted granted Critical
Publication of KR890004558B1 publication Critical patent/KR890004558B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Abstract

4-Amino-6,7-dimethoxy quinazoline derivs of formula (I) and their acid addn. salt are prepd. by reacting a cpd of formula (II) with a cpd. of formula (III) in the presence of C1-4 lower alcohol, formamide, dimethyl formamide, dimethylacetamide or dimethylsulfoxide at an elevated temperature. In the formulas, R is furyl, tetrahydrofuryl, 1,4-benzodioxan-2-yl or butanoyl; n is 2 or 3. (I) are useful as an antihyper tensive agent.

Description

4-아미노-6, 7-디 메톡시 퀴나졸린 유도체의 제조방법Method for preparing 4-amino-6, 7-dimethoxy quinazoline derivative

본 발명은 구조식(Ⅰ)을 갖는 4-아미노-6, 7-디 메톡시 퀴나졸린 유도체 및 그의 산부가염의 제조방법에 관한 것이다.The present invention relates to a 4-amino-6, 7-dimethoxy quinazoline derivative having structural formula (I) and a process for preparing acid addition salts thereof.

Figure kpo00001
Figure kpo00001

여기에서 R은 푸릴, 테트라하이드로푸릴, 1,4-벤조디옥산-2-일, 혹은 5개 이하의 탄소원자를 갖는 알킬기등을 표시하며, n은 2 또는 3의 정수를 나타낸다.Here, R represents furyl, tetrahydrofuryl, 1,4-benzodioxan-2-yl, or an alkyl group having 5 or less carbon atoms, and n represents an integer of 2 or 3.

상기 화합물은 공지의 화합물로서 고혈압치료 효과가 좋은 약물로 소개되어져 있다. 상기 구조식(Ⅰ)의 화합물을 제조하는 공지방법으로는 미국 특허 제 4,026,894, 4,062,844, 4,138,561호 및 독일 특허 제 2,457,911, 2,646,186, 2,725,019, 2,731,737, 2,831,112, 2,847,623, 3,002,553호와 영국 특허 제 1,156,973, 1,543,668호 그리고 일본 공개 특허 제75-140,474, 76-80,877, 76-82,285, 81-103,177호, 프랑스 특허 제2,475,548호, 네덜란드 특허 제 7,206,067호, 벨기에 특허 제 861,821호, 카나다 특허 제 1,088,059호 등에 기술되어 있는 바 그 방법들을 분류해 보면 다음과 같다.The compound has been introduced as a known compound with a high antihypertensive effect. Known methods for preparing the compounds of formula (I) include U.S. Pat. Bars described in Japanese Patent Laid-Open Nos. 75-140,474, 76-80,877, 76-82,285, 81-103,177, French Patent 2,475,548, Netherlands Patent 7,206,067, Belgium Patent 861,821, Canadian Patent 1,088,059, etc. The methods are classified as follows.

첫째로, 하기의 반응식과 같은 구조식(Ⅱ)의 퀴나졸린 유도체와 구조식(Ⅲ)의 피페라진 유도체를 반응시켜 목적화합물(Ⅰ)을 얻는 방법이 소개되어 있다.First, a method of obtaining the target compound (I) by reacting a quinazoline derivative of formula (II) with a piperazine derivative of formula (III), as shown in the following scheme, is introduced.

Figure kpo00002
Figure kpo00002

여기서 R은 푸릴, 테트라하이드로푸릴, 1, 4-벤조디옥산-2-일, 혹은 5개 이하의 탄소원자를 갖는 알킬기이며, n은 2 혹은 3의 정수를 나타내며, X는 염소 혹은 메틸티오기를 표시한다.R is furyl, tetrahydrofuryl, 1, 4-benzodioxan-2-yl, or an alkyl group having 5 or less carbon atoms, n represents an integer of 2 or 3, and X represents a chlorine or methylthio group. do.

이 방법은 수율도 높지않을 뿐더러 구조식(Ⅱ)의 화합물의 제조공정이 길어 경제적이지 못하다는 단점이 있으며, 특히 X가 메틸티오기일 경우 구조식 (Ⅱ)의 화합물을 얻는 반응공정은 더욱 길어지고 구조식(Ⅲ)과의 반응수율은 더 낮았다.This method is not only high in yield, but also has a disadvantage in that it is not economical because the process for preparing the compound of formula (II) is long. Especially, when X is a methylthio group, the reaction process for obtaining the compound of formula (II) becomes longer and The yield of reaction with Ⅲ) was lower.

둘째로, 하기와 같이 구조식(Ⅱ)의 퀴나졸린 유도체와 구조식(Ⅳ)의 피페라진 화합물을 먼저 반응시켜서 얻어진 구조식(Ⅴ)의 중간화합물을 산염화물 R-C-X'와 아실화 반응시켜 구조식(Ⅰ)의 목적화합물을 얻는 방법이 소개되어 있다.Second, the intermediate compound of formula (V) obtained by first reacting the quinazoline derivative of formula (II) with the piperazine compound of formula (IV) as described below was subjected to the acylation reaction of acid chloride RC-X 'with the structural formula (I). A method for obtaining the desired compound is introduced.

Figure kpo00003
Figure kpo00003

여기서 R은 푸릴, 테트라하이드로푸릴, 1,4-벤조디옥산-2-일, 혹은 5개 이하의 탄소원자를 갖는 알킬기이며, n은 2 혹은 3의 정수, X는 염소기를 표시한다. 이 방법은 첫째방법 보다도 수율이 더 낮고 공정도 더 길다.R is furyl, tetrahydrofuryl, 1,4-benzodioxan-2-yl, or an alkyl group having 5 or less carbon atoms, n is an integer of 2 or 3, and X represents a chlorine group. This method has lower yield and longer process than the first method.

셋째로, 하기와 같이 상기의 둘째방법에서 얻은 구조식(Ⅴ)의 중간화합물을 브롬화시안과 반응시킨 후 얻어지는 구조식(Ⅵ)의 반응중간체와 R기의 카르보옴이온에 상응하는 MR와 반응시켜 구조식(Ⅰ)의 목적화합물을 얻는 방법이 소개되어 있다.Third, the intermediate compound of formula (V) obtained in the second method as described above is reacted with cyanide bromide and then reacted with the reaction intermediate of formula (VI) and MR corresponding to the carboon ion of the R group, A method for obtaining the target compound of I) is introduced.

Figure kpo00004
Figure kpo00004

여기서 R과 n은 첫째 방법에서 표시된 바와 동일하고 MR은 M이 나트륨, 리튬으로 이루어지는 카르보옴 이온화 경금속화합물을 표시한다.Where R and n are the same as indicated in the first method and MR denotes the carbo-ionized light metal compound in which M is sodium and lithium.

이 방법은 여타 방법에 비해서 수율이 떨어짐은 물론 실용적인 생산방법이 못된다.This method is lower in yield than other methods and is not a practical production method.

넷째로, 하기와 같이 구조식(Ⅶ)의 2-아미노-4, 5-디 메톡시 벤조니트릴과 구조식(Ⅷ)의 피페라진 유도체를 염기 존재하에서 반응시켜 구조식(Ⅰ)의 목적화합물을 얻는 방법이 소개되어 있다.Fourth, a method of obtaining the target compound of formula (I) by reacting 2-amino-4, 5-dimethoxy benzonitrile of formula (VII) with a piperazine derivative of formula (VII) in the presence of a base as follows: It is introduced.

Figure kpo00005
Figure kpo00005

여기서 R과 n은 첫째방법에서 표시한 바와 동일하고 Y는 H2N - C -, N≡C-, R'Z-C -, m은 0 혹은 1의 정수를 표시하며, 상기식에서 R'은 메틸 혹은 에틸기, Z는 산소 혹은 유황을 나타낸다. 또한 사용된 염기로는 삽급아민 혹은 MR2와 같은 금속염기로서 M은 리튬, 나트륨, R2는 페닐, 수소, 메톡시, 에톡시등을 표시한다.Where R and n are the same as indicated in the first method, Y is H 2 N-C-, N≡C-, R'ZC-, m represents an integer of 0 or 1, wherein R 'is methyl or Ethyl group, Z represents oxygen or sulfur. In addition, as the base used, a metal base such as a quaternary amine or MR 2 , M represents lithium, sodium, and R 2 represents phenyl, hydrogen, methoxy, ethoxy and the like.

이 방법에서 사용되는 염기는 과량이 사용되며, 수율이 저조하고, 특히 금속염기를 사용할 경우 부반응에 의한 불순물이 많이 생성되므로 실용적인 방법이 되지 못한다.The base used in this method is used in excess, poor yield, especially when using a metal base is not a practical method because a lot of impurities are generated by side reactions.

다섯째로, 하기와 같이 구조식(Ⅶ)의 2-아미노-4, 5-디 메톡시 벤조니트릴로부터 몇가지 공정을 거쳐 고리화 반응시켜 목적물(Ⅰ)을 얻는 방법이 소개되어져 있다.Fifth, the method of obtaining the target object (I) by carrying out the cyclization reaction from the 2-amino-4 and 5-dimethoxy benzonitrile of structural formula (V) through several processes is introduced as follows.

Figure kpo00006
Figure kpo00006

여기서 R과 n은 첫째 방법에서 표시한 바와 동일하다.Where R and n are the same as indicated in the first method.

이 방법은 각 공정에서의 반응수율은 좋은 편이나 주요 출발물질인 구조식(Ⅶ)로부터의 반응공정이 길다는 점과 최종 고리화 반응에서 고온반응 및 장시간 반응이 요구되는 불편한 점이 많다.This method has good reaction yield in each process, but the reaction process from the structural formula, which is the main starting material, is long, and there are many inconveniences that require high temperature reaction and long time reaction in the final cyclization reaction.

여섯째로, 구조식(Ⅸ)의 3, 4-디 메톡시 아닐린으로부터 다섯째 방법과 유사한 몇가지 공정을 거쳐 할로겐화 인산화합물을 사용하여 고리화 반응시켜 최종 목적물(Ⅰ)을 얻는 방법이 소개되어 있다.Sixth, a method of obtaining the final target (I) by cyclization using a halogenated phosphate compound through several processes similar to the fifth method from 3,4-dimethoxyaniline of formula (VII) is introduced.

Figure kpo00007
Figure kpo00007

여기서 R과 n은 첫째 방법에서 표시한 바와 동일하고 POX3, PX3, PX5에서의 X는 염소 혹은 브롬이다.Where R and n are the same as indicated in the first method and X in POX 3 , PX 3 , PX 5 is chlorine or bromine.

이 방법은 전반적으로 다섯째 방법과 유사하나 반응중간물질과 구조식(X)으로 부터 요오드메탄 및 시안아미드와의 반응공정(A)을 거쳐 중간체(XI)을 얻는 수율이 저조하여 다섯째 방법에 비해 경제적인 방법이 되지 못하였다.This method is similar to the fifth method in general, but the yield of obtaining intermediate (XI) through the reaction process (A) of iodine methane and cyanamide from reaction intermediate and structural formula (X) is low. There was no way.

이외에 하기와 같이 금속촉매하에서 탈할로겐화 및 수소화 반응을 통하여 목적물(Ⅰ)을 얻는 방법이 발표되었으나 이 방법들은 상기의 여섯가지 방법들에 비하면 상당히 우회적인 방법임을 물론, 수율도 낮아 공업적으로 중요한 방법이라고는 할 수 없다.In addition, a method of obtaining a target (I) through dehalogenation and hydrogenation under a metal catalyst has been published as follows. However, these methods are considerably bypassed compared to the above six methods, and the yield is also low. It cannot be said.

Figure kpo00008
Figure kpo00008

여기서 R 및 n은 첫째 방법에서 표시한 바와 동일하고, X는 염소, 브롬, 요오드와 같은 할로겐 원자이며, 사용된 금속촉매는 백금, 팔라듐, 구리, 코발트, 니켓 등의 중금속들이다.Where R and n are the same as indicated in the first method, X is a halogen atom such as chlorine, bromine and iodine, and the metal catalysts used are heavy metals such as platinum, palladium, copper, cobalt and nickel.

본 발명은 선행 제조방법들의 단점들을 보완한 새로운 방법으로서 간단한 공정과 좋은 수율로 고순도의 목적화합물(Ⅰ)을 쉽게 제조하는 방법을 제공하는 것이다.The present invention provides a method for easily preparing a high purity target compound (I) with a simple process and a good yield as a new method to supplement the disadvantages of the preceding manufacturing methods.

본 발명의 방법을 반응식으로 표시하면 하기의 [반응공정도 Ⅰ]과 같다.When the method of the present invention is represented by the reaction scheme, it is as follows [reaction process chart I].

Figure kpo00009
Figure kpo00009

여기서 R은 푸릴, 테트라하이드로푸릴, 1, 4-벤조디옥산-2-일, 혹은 5개 이하의 탄소원자를 갖는 알킬기등을 표시하며, n은 2 또는 3의 정수이다.R represents furyl, tetrahydrofuryl, 1, 4-benzodioxan-2-yl, or an alkyl group having 5 or less carbon atoms, and n is an integer of 2 or 3.

또한 본 발명에서 사용된 구조식(XⅡ)의 이미드 아미도 벤조니트릴 유도체는 피페라진 화합물로부터 하기의 반응공정도 Ⅱ와 같이 제조되며 상세한 제조방법을 실시예에 명기하였다.In addition, the imide amido benzonitrile derivative of the structural formula (XII) used in the present invention is prepared from the piperazine compound in the following reaction process diagram II, and detailed preparation methods are specified in the examples.

Figure kpo00010
Figure kpo00010

여기서 R과 n은 (반응공정도 Ⅰ)에서 표시한 바와 동일하며 R3는 알킬기로서 특히 메틸, 에틸이며, 이 공정에서는 구조식(XIV)의 공지화합물로부터 제조되는 구조식(XV)의 포름이미데이트 유도체와 공지의 화합물인 구조식(Ⅶ)의 2-아미노-4, 5-디 메톡시 벤조니트릴과 반응시킴에 있어서, 탄소수 1-4의 저급알콜, 혹은 벤젠, 톨루엔과 같은 방향족 유기용매, 혹은 염화메틸렌, 염화에틸렌, 클로포름과 같은 염화알칸류의 용매 혹은 아세톤, 에틸아세테이트, 아세토니트릴, 테트라하이드로퓨란, 에테르, 포름아미드, 디 메틸포름 아미드와 같은 비 양성자성 극성 용매존재하에서 40-180℃사이에서 반응시키며, 특히 메틸알콜, 에틸알콜과 같은 저급알콜에서 환류반응시켜, 본 발명의 중간물질인 구조식(XⅡ)의 이미드 아미도 벤조니트릴 유도체를 얻는다.Wherein R and n are the same as those shown in (Reaction Step I), and R 3 is an alkyl group, in particular methyl and ethyl, and in this process, the formimidate derivative of formula (XV) prepared from a known compound of formula (XIV) In reaction with 2-amino-4, 5-dimethoxy benzonitrile of the structural formula (Ⅶ) which is a well-known compound, C1-C4 lower alcohol, or aromatic organic solvent, such as benzene and toluene, or methylene chloride , Solvents of alkane chlorides such as ethylene chloride, chloroform or aprotic polar solvents such as acetone, ethyl acetate, acetonitrile, tetrahydrofuran, ether, formamide, dimethylformamide, between 40-180 ° C. The reaction is carried out under reflux, particularly in lower alcohols such as methyl alcohol and ethyl alcohol, to obtain an imide amido benzonitrile derivative of formula (XII), which is an intermediate of the present invention.

본 발명은, (반응공정도 I )에서 보는 바와같이 (반응공정도Ⅱ)로부터 제조될 수 있는 구조식( XⅡ)의 화합물에 구조식(XIII)의 피리딘 염산염을 가하여 고리화 반응시켜 구조식( I)의 목적화합물을 좋은 수율과 고순도로 쉽게 얻는 방법이다.The present invention provides a compound of formula (I) by cyclization by adding a pyridine hydrochloride of formula (XIII) to a compound of formula (XII), which can be prepared from It is an easy method to obtain the target compound with good yield and high purity.

이 공정에서 용매로는 탄소수 1-4의 저급알콜 혹은 포름아미드, 디 메틸 포름아미드, 디 메틸 아세트 아미드, 디 메틸 술폭사이드와 같으 비 양성자성 극성 용매 존재하에서 또는 이들사이의 혼합용매 혹은 이들 이외의 다른 유기용매 즉, 염화메틸렌, 클로로포름, 아세톤, 염화에틸렌, 에틸아세테이트, 에테르를 사용하여 60°내지 150℃사이에서 가온반응하여 고리화시켜 좋은 수율로 고순도의 목적화합물인 구조식(Ⅰ)의 화합물의 산부가염을 얻는다.In this process, the solvent may be a lower alcohol or formamide having 1 to 4 carbon atoms, dimethyl formamide, dimethyl acetamide, dimethyl sulfoxide in the presence of a non-protic polar solvent or a mixed solvent therebetween or other The compound of formula (I), which is a target compound of high purity with good yield, is cyclized by heating at 60 ° to 150 ° C. using another organic solvent such as methylene chloride, chloroform, acetone, ethylene chloride, ethyl acetate, and ether. Get acid addition salts.

본 발명은 목적화합물의 선행제조방법이나 목적화합물의 유사 유도체에 대한 선행방법들에 비해,The present invention is compared with the preceding methods for the preparation of the target compound or similar methods for analogous derivatives of the target compound.

1. 반응공정이 간단하며,1. The reaction process is simple,

2. 취급이 난이한 카르보음이온화 경금속화합물을 사용치 않고도 좋은 수율로 반응을 진행시킬 수 있으며,2. The reaction can be proceeded in good yield without using hard carboionized light metal compound,

3. 간단한 조작으로 목적화합물을 고순도로 분리해 낼 수 있다는 장점이 있다.3. It has the advantage of being able to separate the target compound with high purity by simple operation.

본 발명에 따른 방법으로 여러가지의 고혈압 치료제인 퀴나졸린 유도체를 얻을 수 있다.The method according to the present invention can yield various quinazoline derivatives which are therapeutic agents for hypertension.

실시예에 언급된 물질이외에도 특히 다음과 같은 물질들은 본 발명의 방법으로 쉽게 얻을 수 있다.In addition to the materials mentioned in the examples, in particular the following materials can be easily obtained by the method of the present invention.

본 발명의 제조할 수 있는 화합물들로서는 4-아미노-2[4-(1-옥소부틸)호모피페라진-1-일]-6, 7-디 메톡시 퀴나졸린 및 그의 염화수소, 브롬화수소, 요오드화수소, 알킬 혹은 아릴술폰산염 및 그의 수화물 및 4-아미노-2-[4-(테트라하이드로-2-푸로일-1-피페라진일]-6, 7-디 메톡시 퀴나졸린 및 그의 염화수소, 브롬화수소, 요오드화수소, 알킬 혹은 아릴술폰산염 및 그의 수화물 등이 속한다.Compounds that can be prepared of the present invention include 4-amino-2 [4- (1-oxobutyl) homopiperazin-1-yl] -6, 7-dimethoxy quinazoline and its hydrogen chloride, hydrogen bromide, iodide Hydrogen, alkyl or arylsulfonates and their hydrates and 4-amino-2- [4- (tetrahydro-2-furoyl-1-piperazinyl] -6, 7-dimethoxy quinazoline and its hydrogen chloride, brominated Hydrogen, hydrogen iodide, alkyl or arylsulfonate salts, and hydrates thereof.

다음에 본 발명을 좀더 상세히 설명해 주기 위하여 실시예들을 열거하였으며, 이들 실시예에 의하여 본 발명의 기술내용이 한정되는 것은 아니다.In the following, embodiments are listed in order to explain the present invention in more detail, and the technical details of the present invention are not limited to these examples.

[실시예 1]Example 1

1-시아노-4-(2-푸로일)피페라진의 제조Preparation of 1-cyano-4- (2-furoyl) piperazine

무수피페라진 8.61g(0.1몰)을 실온에서 무수클로로포름 50ml에 녹이고, 트리에틸아민 13.9ml을 가한다. 여기에 부름화시안 10.6g(0.1몰)을 무수클로로포름 50ml에 녹인 용액을 15분간 실온에서 적하하고 실온에서 2시간 동안 교반시킨 다음 2N-NaOH용액으로 pH10으로 맞추고 분리한다.8.61 g (0.1 mol) of anhydrous piperazine was dissolved in 50 ml of anhydrous chloroform at room temperature, and 13.9 ml of triethylamine was added. Here, a solution of 10.6 g (0.1 mol) of cyanide in 50 ml of anhydrous chloroform was added dropwise at room temperature for 15 minutes, stirred at room temperature for 2 hours, adjusted to pH 10 with 2N-NaOH solution, and separated.

물층을 다시 클로로포름 각 45ml로 2회 추출하여 앞서 분리된 유기층과 혼합하여 탄산칼륨 15g으로 건조하고 여과한다.The water layer was extracted twice with 45 ml each of chloroform, mixed with the previously separated organic layer, dried over 15 g of potassium carbonate and filtered.

여액을 감압증발시켜서 70ml로 농축시키고 트리에틸아민 11.8ml을 가하고 0-5℃로 냉각하여 2-푸로일 클로라이드 9.8g(0.1몰)을 30분간 적하하고 실온에서 교반한다.The filtrate was evaporated under reduced pressure, concentrated to 70 ml, 11.8 ml of triethylamine was added, cooled to 0-5 ° C., and 9.8 g (0.1 mol) of 2-furoyl chloride was added dropwise for 30 minutes and stirred at room temperature.

박층크로마토그라피(실리카겔, 초산 : 노르말부틸알콜 : 물 = 1 : 4 : 5)로 반응진행 상태를 추적하면서 반응완결한 후 반응액에 물 30ml를 가하고 2N-염산으로 pH2로 조절하여 유기층을 분리한다.After completion of the reaction by tracking the reaction progress with thin layer chromatography (silica gel, acetic acid: normal butyl alcohol: water = 1: 4: 5), 30 ml of water was added to the reaction solution, and the organic layer was separated by adjusting to pH 2 with 2N hydrochloric acid. do.

유기층에 다시 물 30ml를 가하고 2N-NaOH용액으로 pH9로 조절하여 실온에서 충분히 교반한 후 분리된 유기층에 망초 10g을 가하여 건조하고 여액층의 유기용매를 감압증발시키면 잔유물인 1-시아노-4-(2-푸로일)피페라진 16.7g을 얻는다.30 ml of water was added to the organic layer again, adjusted to pH 9 with 2N-NaOH solution, stirred sufficiently at room temperature, and dried by adding 10 g of forget-me-not to the separated organic layer, and evaporating the organic solvent of the filtrate layer under reduced pressure. Obtain 16.7 g of (2-furoyl) piperazine.

수율 : 81%Yield: 81%

융점 : 63-65℃Melting Point: 63-65 ℃

또한, 실시예 1의 방법에 따를 경우 다음과 같은 구조식(XIV)의 화합물을 제조할 수 있다.In addition, according to the method of Example 1 it can be prepared a compound of formula (XIV) as follows.

Figure kpo00011
Figure kpo00011

[실시예 4]Example 4

메틸[4-(2-푸로일)피페라진-1-일]포름아미데이트(XV)의 제조Preparation of Methyl [4- (2-furoyl) piperazin-1-yl] formamidate (XV)

실시예 1에서 얻은 1-시아노-4-(2-푸로일)피페라진 16.7g(0.08몰)을 실온에서 무수메틸알콜 80ml에 용해하고 실온에서 무수염산 가스를 서서히 주입하면서 교반한다.16.7 g (0.08 mol) of 1-cyano-4- (2-furoyl) piperazine obtained in Example 1 was dissolved in 80 ml of anhydrous methyl alcohol at room temperature, and stirred while slowly injecting anhydrous hydrochloric acid gas at room temperature.

박층크로마토그라피(실리카겔, 에틸아세테이트 : 디에틸아민 = 95 : 5)로 추적하여 반응완결시키고 충분히 감압증발시켜서 얻어진 백색분말에 아세톤 400ml을 가하고 피리딘 12ml(0.15몰)을 가하여 상온에서 1시간 교반하고 여과한 후 여액중의 용매를 충분히 감압증발시키면 잔유물이 에틸[4-(2-푸로일)피페라진-1-일]포름이미데이트 19.1g을 얻는다.After completion of reaction by thin layer chromatography (silica gel, ethyl acetate: diethylamine = 95: 5), 400 ml of acetone was added to the white powder obtained by evaporation under reduced pressure, 12 ml (0.15 mole) of pyridine was added, and the mixture was stirred at room temperature for 1 hour and filtered. After evaporation of the solvent in the filtrate sufficiently under reduced pressure, the residue yielded 19.1 g of ethyl [4- (2-furoyl) piperazin-1-yl] formimidate.

수율 : 98%Yield: 98%

비점 : 84℃Boiling Point: 84 ℃

또한, 실시예 4의 방법에 따를 경우 다음과 같은 구조식(XV)의 화합물을 제조할 수 있다.In addition, according to the method of Example 4 it can be prepared a compound of the following structural formula (XV).

Figure kpo00012
Figure kpo00012

[실시예 7]Example 7

3,4-디 메톡시-6-[4-(2-푸로일)피페라진-1-일]포름이미드 아미도 벤조니트릴(XⅡ)의 제조.Preparation of 3,4-dimethoxy-6- [4- (2-furoyl) piperazin-1-yl] formimide amido benzonitrile (XII).

실시예 4에서 얻은 메틸[4-(2-푸로일)피페라진-1-일]포름이미데이트 12g(0.05몰)과 2-아미노-4,5-디메톡시 벤조니트릴 10.7g(0.06몰)을 실온에서 무수에탄올 200ml에 녹인 다음 8시간 동안 환류반응하면서 박층크로마토그라피(실리카겔, 에틸아세테이드 : 디에틸아민 =95 :5)로 반응완결을 확인한 후 용매를 충분히 감압증발시킨다.12 g (0.05 mol) of methyl [4- (2-furoyl) piperazin-1-yl] formimidate obtained in Example 4 and 10.7 g (0.06 mol) of 2-amino-4,5-dimethoxy benzonitrile were prepared. After dissolving in 200 ml of anhydrous ethanol at room temperature and refluxing for 8 hours, the reaction was confirmed by thin layer chromatography (silica gel, ethyl acetate: diethylamine = 95: 5), and then the solvent was evaporated sufficiently under reduced pressure.

잔액에 염화메틸렌 400ml와 물 100ml를 가하고 2N-HC1로 pH2로 조절하여 분리하고, 물층에 염화메틸렌 200ml를 가하고 2N-NaOH용액으로 pH10으로 조절하여 분리한다. 분리한 염화메티렌층을 망초 15g을 가해 건조하고 여과하여 여액중의 유기용매를 감압증발시키면 잔유물인 3,4- 디 메톡시-6-[4-(2-푸로일)피페라진-1-일]포름이미드 아미도 벤조니트릴 17.7g을 얻는다.400 ml of methylene chloride and 100 ml of water were added to the residue, and the mixture was separated by adjusting to pH 2 with 2N-HC1. 200 ml of methylene chloride was added to the water layer and separated by adjusting to pH 10 with 2N-NaOH solution. 15 g of the separated methylene chloride layer was added with 15 g of forget-me-not, dried and filtered, and the organic solvent in the filtrate was evaporated under reduced pressure to give 3,4-dimethoxy-6- [4- (2-furoyl) piperazin-1-yl as a residue. ] 17.7 g of formimide amido benzonitrile is obtained.

수율 : 92%Yield: 92%

융점 : 108-110°Melting Point: 108-110 °

IR(KBr,Cm-1)3400,3275,3095,2900,2215,1623,1587,1516,1409,1226,1212,862,836,745IR (KBr, Cm -1 ) 3400,3275,3095,2900,2215,1623,1587,1516,1409,1226,1212,862,836,745

또한 실시예 7의 방법에 따를 경우 다음과 같은 구조식(XⅡ)의 화합물을 제조할 수 있다.In addition, according to the method of Example 7 it can be prepared a compound of formula (XII) as follows.

Figure kpo00013
Figure kpo00013

[실시예 10]Example 10

2-[4-(2-푸로일)피페라진-1-일]-4-아미노-6, 7-디 메톡시 퀴나졸린 염산염의 제조Preparation of 2- [4- (2-furoyl) piperazin-1-yl] -4-amino-6, 7-dimethoxy quinazoline hydrochloride

실시예 7에서 얻은 3, 4-디 메톡시-6-[4-(2-푸로일)피페라진-1-일]포름이미드아미도 벤조니트릴 9.7g(0.02몰)을 실온에서 무수메틸알콜 200ml에 녹이고 피리딘의 염산염 6.9g(0.06몰)을 가하여 박층크로마토그라피(실리카겔, 초산 : 노르말부틸알콜 : 물= 1 : 4 : 5)로 반응추적하면서 더이상 반응이 진행되지 않을 때까지 환류 교반한다.9.7 g (0.02 mol) of 3,4-dimethoxy-6- [4- (2-furoyl) piperazin-1-yl] formimamidobenzonitrile obtained in Example 7 was dried at room temperature with methyl alcohol. Dissolve in 200ml and add 6.9 g (0.06 mol) of pyridine hydrochloride and trace the reaction with thin layer chromatography (silica gel, acetic acid: normal butyl alcohol: water = 1: 4: 5) while stirring under reflux until no further reaction proceeds.

용매를 가압증발시킨 후 염화메틸렌 120ml를 가하고 실온에서 무수염화수소가스를 2시간에 걸쳐 천천히 주입하면서 백색분말이 석출된다. 용매를 감압증발시키고 물 8ml를 가하여 30분간 교반한 후 여과한 다음 아세톤 40ml로 2회 분할하여 세척하면 2-[4-(2-푸로일)피페라진-1-일]-1-아미노-6, 7-디메톡시 퀴나졸린의 염산염 8.1g을 얻는다.After evaporating the solvent under pressure, 120 ml of methylene chloride is added, and white powder is precipitated by slowly injecting anhydrous hydrogen chloride gas at room temperature over 2 hours. The solvent was evaporated under reduced pressure, 8 ml of water was added thereto, stirred for 30 minutes, filtered, and the mixture was washed twice with 40 ml of acetone and washed with 2- [4- (2-furoyl) piperazin-1-yl] -1-amino-6 , 8.1 g of hydrochloride of 7-dimethoxy quinazoline is obtained.

수율 : 76.3%Yield: 76.3%

융점 : 278-280℃Melting Point: 278-280 ℃

IR(KBr,Cm-1) : 3320, 3225, 3075, 2856, 1634, 1596, 1480, 1467, 1425, 1280, 795, 763, 750, 720, 717, 675.IR (KBr, Cm −1 ): 3320, 3225, 3075, 2856, 1634, 1596, 1480, 1467, 1425, 1280, 795, 763, 750, 720, 717, 675.

또한 실시예 10의 방법에 따를 경우 다음과 같은 구조식(Ⅰ)의 화합물을 제조할 수 있다.In addition, according to the method of Example 10 it can be prepared a compound of formula (I) as follows.

Figure kpo00014
Figure kpo00014

Claims (5)

다음 구조식(XⅡ)의 화합물을 구조식(XⅢ)의 화합물과 유기 용매존재하 가온상태에서 고리화 반응시킴을 특징으로 하는 구조식(Ⅰ)의 화합물 및 그의 산부가염을 제조하는 방법.A process for preparing a compound of formula (I) and an acid addition salt thereof, wherein the compound of formula (XII) is cyclized with a compound of formula (XIII) in a warm state in the presence of an organic solvent.
Figure kpo00015
Figure kpo00015
상기식에서 R은 푸릴, 테트라하이드로푸릴, 1,4-벤조디옥산-2-일, 도는 부타노일기이며, n은 2 또는 3의 정수이다.Wherein R is furyl, tetrahydrofuryl, 1,4-benzodioxan-2-yl, or butanoyl group, n is an integer of 2 or 3.
제 1 항에 있어서, 유기용매로서 탄소수 1-4의 저급알콜, 포름아미드, 디메틸포름아미드, 디메탈아세트아미드, 디메틸솔폭시드와 같은 극성용매중에서 선택하거나 이들 사이의 혼합용매 혹은 이외의 다른 유기용매와의 혼합용매를 사용함을 특징으로 하는 제조방법.The organic solvent according to claim 1, selected from polar solvents such as lower alcohols having 1 to 4 carbon atoms, formamides, dimethylformamides, dimetalacetamides, dimethylsulfoxides, mixed solvents therebetween or other organic solvents therebetween. Method for producing a mixed solvent with. 제 2 항에 있어서, 탄소수 1-4의 저급알콜 용매로서 메틸알콜 또는 에틸알콜을 사용함을 특징으로 하는 제조방법.The method according to claim 2, wherein methyl alcohol or ethyl alcohol is used as the lower alcohol solvent having 1 to 4 carbon atoms. 제 2 항에 있어서, 다른 유기용매로서 염화메틸렌 , 클로로포름, 아세톤, 염화에틸렌, 에틸아세테이트, 에테르를 사용함을 특징으로 하는 제조방법.The process according to claim 2, wherein methylene chloride, chloroform, acetone, ethylene chloride, ethyl acetate, and ether are used as another organic solvent. 제 1 항에 있어서, 반응온도는 60-150℃에서 행함을 특징으로 하는 제조방법.The process according to claim 1, wherein the reaction temperature is carried out at 60-150 ° C.
KR1019870007670A 1987-07-15 1987-07-15 Process for preparing 4-amino-6,7-dimethoxy quinazoline derivatives KR890004558B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1019870007670A KR890004558B1 (en) 1987-07-15 1987-07-15 Process for preparing 4-amino-6,7-dimethoxy quinazoline derivatives
ES8802218A ES2007263A6 (en) 1987-07-15 1988-07-14 4-Amino 6,7-di:methoxy quinazoline deriv. prepn. - by cyclising reaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870007670A KR890004558B1 (en) 1987-07-15 1987-07-15 Process for preparing 4-amino-6,7-dimethoxy quinazoline derivatives

Publications (2)

Publication Number Publication Date
KR890002125A KR890002125A (en) 1989-04-08
KR890004558B1 true KR890004558B1 (en) 1989-11-15

Family

ID=19263024

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870007670A KR890004558B1 (en) 1987-07-15 1987-07-15 Process for preparing 4-amino-6,7-dimethoxy quinazoline derivatives

Country Status (2)

Country Link
KR (1) KR890004558B1 (en)
ES (1) ES2007263A6 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000011791A (en) * 1998-07-17 2000-02-25 이데이 노부유끼 Signal processing apparatus, control method for signal processing apparatus, imaging apparatus and recording/reproducing apparatus

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100446864B1 (en) * 2002-02-06 2004-09-04 에이티엔써플라이 주식회사 St0rage glow license number plate and manufacturing process thereof
KR102372588B1 (en) * 2021-09-09 2022-03-10 김학도 Vehicle license plate laminate film attachment device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000011791A (en) * 1998-07-17 2000-02-25 이데이 노부유끼 Signal processing apparatus, control method for signal processing apparatus, imaging apparatus and recording/reproducing apparatus

Also Published As

Publication number Publication date
KR890002125A (en) 1989-04-08
ES2007263A6 (en) 1989-06-01

Similar Documents

Publication Publication Date Title
HU187562B (en) Process for the preparation of 3,4-dihydro-2-bracket-1h-bracket closed-imino-quinazolin-3-acetic acid derivatives
CN111315742B (en) Process for preparing aminopyrimidine derivatives
KR890004558B1 (en) Process for preparing 4-amino-6,7-dimethoxy quinazoline derivatives
KR890001147B1 (en) Preparation method of 2-substituted or unsubstituted aminocarbonyl oxyalkyl-1,4-dihydropyridines
KR20040007978A (en) A process for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
SU591149A3 (en) Method of preparing derivatives of triazoloisoquinoline
JP4026233B2 (en) Method for producing 4,5-dichloro-6- (α-fluoroalkyl) pyrimidine
NO147838B (en) INTERMEDIATE FOR USE IN PREPARATION OF THE HYPOTENSIVE AGENT 2- (4- (2-FUROYL) PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXYKINAZOLINE
SU474985A3 (en) The method of obtaining 1-alkyl-4-phenyl-2 (1H) quinazolinone
EP1065202B1 (en) 6-(alpha-fluoroalkyl)-4-pyrimidones and process for producing the same
JPH02289563A (en) Improved process for producing ortho-carboxypyridyl- and ortho-carboxyquinolylimidazolinones
HU219231B (en) N-5-protected 2,5-diamino-4,6-dichloro-pyrimidine derivatives , process for producing them and intermediates
US4985563A (en) Process for the preparation of 6-piperidino-2,4-diamino pyrimidine-3-oxide
JP3018296B2 (en) Method for producing glycidyl ether
HUT72757A (en) 3-substituted 5-quinolinecarboxylicacid-derivatives and process for their preparation
Elgemeie et al. NOVEL SYNTHESIS OF PYRIDINE-2 (1H) THIONES, N-AMINO-2-PYRIDONES AND PYRIDAZINE DERIVATIVES
US4423219A (en) Production of purine derivatives and intermediates therefor
KR960010351B1 (en) Process for the preparation of benzoxazine derivative
EP0034421B1 (en) N-phenyl-n'-cyano-0-phenylisoureas and process for their preparation
NO882085L (en) CYKLOBUTENMELLOMPRODUKT.
US5286861A (en) Process for preparing uracil derivatives
US6593475B1 (en) Preparation of derivative of 3-sulfonamido-4-phenylaminopyridine
PL164340B1 (en) Method of obtaining novel benzothiazine derivatives
GB2102800A (en) Pyrimidines
JP4055246B2 (en) 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930429

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee